The major safety endpoints are the common side effects of IFNa therapy including flu-like symptoms, depression, and hematologic abnormalities. [clinicaltrials_resource:e77a19fd5e9c0044c3c82d41b2c04a1a]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
The major safety endpoints are the common side effects of IFNa therapy including flu-like symptoms, depression, and hematologic abnormalities. [clinicaltrials_resource:e77a19fd5e9c0044c3c82d41b2c04a1a]
Bio2RDF identifier
e77a19fd5e9c0044c3c82d41b2c04a1a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e77a19fd5e9c0044c3c82d41b2c04a1a
measure [clinicaltrials_vocabulary:measure]
The major safety endpoints are ...... and hematologic abnormalities.
identifier
clinicaltrials_resource:e77a19fd5e9c0044c3c82d41b2c04a1a
title
The major safety endpoints are ...... and hematologic abnormalities.
@en
type
label
The major safety endpoints are ...... a19fd5e9c0044c3c82d41b2c04a1a]
@en